EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FOSL2 activates TGF ‐β1‐mediated GLUT1 / mTOR signaling to promote diabetic kidney disease

Xuelin He, Min Xia, Guanghui Ying, Qien He, Zhaogui Chen, Li Liu, Qiao Zhang, Jianxin Cai iD

Journal of Diabetes Investigation · 2025

DOI: 10.1111/jdi.14360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Xuelin He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Transforming Growth Factor beta1, TOR Serine-Threonine Kinases, Fos-Related Antigen-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Public Welfare Technology Research Program, Natural Science Foundation of Ningbo Municipality, Traditional Chinese Medicine Research Project of Hubei Provincial Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction Diabetic kidney disease (DKD) is a major cause of kidney failure. FOS‐like antigen 2 (FOSL2) has been revealed to be increased in kidney biopsies of patients with lupus nephritis, while its association with DKD remains unsolved. This study aimed to characterize the role of FOSL2 in DKD and its mechanism.

Method

The kidney tissues of DKD mice induced by STZ and a high‐fat diet were subjected to PAS and Masson's staining. Glomerular mesangial cells (MCs) were treated with high glucose (HG) or normal glucose (NG). CCK‐8 and EdU assays were performed to detect cell proliferation, and immunoblotting was conducted to analyze ECM deposition. ChIP‐qPCR was performed on MCs to detect the binding of FOSL2 on the TGF‐β1 promoter and a dual‐luciferase assay to detect the impact of FOSL2 on the transcription of the TGF‐β1 promoter.

Results

FOSL2 was elevated in the kidney tissues of DKD mice. Knockdown of FOSL2 reduced the mRNA expression of TGF‐β1 to decrease the protein expression of GLUT1 and mTOR in the kidney tissues of DKD mice, and TGF‐β1 reversed the effects caused by knockdown of FOSL2. The mTOR inhibitor Rapamycin alleviated kidney injury in the presence of FOSL2. Knockdown of FOSL2 inhibited the proliferation and improved ECM deposition of MCs, which were reversed by TGF‐β1. Rapamycin and GLUT1 inhibitor BAY‐876 reversed the promotion effect of FOSL2 on the proliferation of NG‐MCs/HG‐MCs and improved ECM deposition of MCs.

Conclusions

Our data demonstrated that FOSL2 accentuates DKD in mice by increasing TGF‐β1‐induced GLUT1/mTOR signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesTransforming Growth Factor beta1TOR Serine-Threonine KinasesFos-Related Antigen-2Glucose Transporter Type 1AnimalsMiceSignal TransductionMaleMice, Inbred C57BLDiabetes Mellitus, ExperimentalHumansCell Proliferation

Stichwörter der Autor:innen

Diabetic kidney diseaseFOSL2GLUT1/mTOR signaling

Substanzen

Transforming Growth Factor beta1TOR Serine-Threonine KinasesFos-Related Antigen-2Glucose Transporter Type 1Fosl2 protein, mousemTOR protein, mouseTgfb1 protein, mouse

Autor:innen und Institutionen

  • Kidney Disease Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Nephrology, Beilun People's Hospital, Ningbo, Zhejiang, China.
  • Department of Library, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Department of Pediatric, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.

ORCID-Profile: Jianxin Cai

Förderung

  • Zhejiang Public Welfare Technology Research Program
  • Natural Science Foundation of Ningbo Municipality
  • Traditional Chinese Medicine Research Project of Hubei Provincial Health Commission
  • the Natural Science Foundation of Hubei Province

Zitieren

APA

He, X., Xia, M., Ying, G., He, Q., Chen, Z., Liu, L., Zhang, Q., & Cai, J. (2025). FOSL2 activates TGF ‐β1‐mediated GLUT1 / mTOR signaling to promote diabetic kidney disease. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14360

Vancouver

He X, Xia M, Ying G, He Q, Chen Z, Liu L, et al. FOSL2 activates TGF ‐β1‐mediated GLUT1 / mTOR signaling to promote diabetic kidney disease. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.14360

BibTeX
@article{He2025,
  author = {He, Xuelin and Xia, Min and Ying, Guanghui and He, Qien and Chen, Zhaogui and Liu, Li and Zhang, Qiao and Cai, Jianxin},
  title = {FOSL2 activates TGF ‐β1‐mediated GLUT1 / mTOR signaling to promote diabetic kidney disease},
  journal = {Journal of Diabetes Investigation},
  year = {2025},
  doi = {10.1111/jdi.14360}
}
Kostenlos starten →